INVA INNOVIVA
Permanent stock page ↗Health Care · Russell 2000
Next earnings: not announced yet
What 7 analyst firms say about INNOVIVA: their latest ratings, price targets and how far the stock is from them. How it works
Analyst window: Latest analyst report within last 1 year
Analyst view · last 1Y
6 rated views · 7 analyst/firm records · 7 firms
Radar score
- Russell 2000 · Top Picks · 6MBelow the Radar threshold of 8053
- Russell 2000 · Safest consensus · 6MBelow the Radar threshold of 8028
Recent analyst activity · last 90 days
Our tracked history has 4 reports on INVA from 3 analyst firms in the last 90 days (7 firms in the past year).
Comparing each firm's latest target with its previous one: 1 lowered it.
No firm's latest available rating differs from its previous one.
Latest observed target change: Oppenheimer lowered its target from $35.00 (set 23 Sep 2026) to $34.00 on 5 Nov 2026.
Last 1 year. Latest opinion per identifiable analyst within the last 1 year. BUY / HOLD / SELL each count one current analyst vote; unnamed firm records are a fallback.
| Firm | Analyst | Latest rating | Report date | Latest target (USD) |
|---|---|---|---|---|
| BTIG | Julian Harrison | Buy | 22 Jun 2026 | 42.00 USD |
| Cantor Fitzgerald | Steve Seedhouse | Buy | 7 Aug 2026 | 34.00 USD |
| Goldman Sachs | Asad Haider | Sell | 25 Jun 2026 | — |
| H.C. Wainwright | Raghuram Selvaraju | Buy | 1 Jun 2026 | 46.00 USD |
| Oppenheimer | Les Sulewski | Buy | 23 Sep 2026 | 35.00 USD |
| Weiss Ratings | Unnamed analyst | — | 24 Sep 2026 | — |
| Data feed RESEARCH | Research Team | Hold | 31 Aug 2026 | — |
Partial coverage · checked 6 Nov (6 Nov 2026, 05:58 ET). Some research records could not be refreshed. Cached records retained. Prices stream live during the US session; otherwise stored prices delayed about 15 minutes. A summary of analyst opinion, not investment advice.